Search results
Found 1078 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Unlocking the secrets of the gut microbiome
General Research
24 November 2023
Undaunted by its complexity, Professor Emma Slack is pioneering new methods of engineering the body’s largest microbiome to improve health and protect against disease.
Oxford-led study shows how AI can detect antibiotic resistance in as little as 30 minutes
General Research
21 November 2023
To mark World Antimicrobial Awareness Week, researchers supported by the Oxford Martin Programme on Antimicrobial Resistance Testing at the University of Oxford have reported advances towards a novel and rapid antimicrobial susceptibility test that can return results within as little as 30 minutes - significantly faster than current gold-standard approaches.
Antimicrobial resistance is a silent killer that leads to 5 million deaths a year. Solutions must include the poor
General Research
17 November 2023
Microbes such as bacteria, viruses, parasites and fungi form part of our everyday lives – they live in us, on us and around us. We need them for healthy digestion, immune function, and the synthesis of essential nutrients, and we depend on them for farming and industrial processes. But microbes also cause disease in people, animals and plants.
Flies neglect food and endure shocks to seek a dopamine reward
General Research
17 November 2023
New research published in nature, led by Department of Physiology, Anatomy and Genetics (DPAG) scientists Dr Kristijan Jovanoski and Professor Scott Waddell at the Centre for Neural Circuits and Behaviour, reveals dopamine systems can cause flies to seek reward despite negative consequences
Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa
General Research
16 November 2023
The Pandemic Sciences Institute (PSI) has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.
£4.3m boost for Oxford-Glasgow spinout tackling antimicrobial resistance
General Research
15 November 2023
Glox Therapeutics, a company pioneering the development of precision antibiotics to combat antimicrobial resistance, has raised £4.3M in early-stage funding to develop effective targeted therapeutics against antibiotic-resistant gram-negative bacteria.
AI tool could help thousands avoid fatal heart attacks
General Research
14 November 2023
An Artificial Intelligence (AI) tool that can predict 10-year risk of deadly heart attacks, could transform treatment for patients who undergo CT scans to investigate chest pain, according to British Heart Foundation-funded research presented today at the American Heart Association’s Scientific Sessions in Philadelphia.
Heart attack risk decreased in new mothers by self-monitoring blood pressure at home
General Research
13 November 2023
Self-monitoring blood pressure after giving birth could help to cut new mothers’ risk of future heart disease and strokes, according to new research by Oxford researchers.
Single cell spatial analysis provides new insight into immune-pathology in Covid-19 lungs
Coronavirus COVID-19 General Research
9 November 2023
A Nature Communications study led by Professor Ling-Pei Ho’s group in the MRC Translational Immune Discovery Unit (TIDU) provides new insights into how immune cells interact in the lungs of patients with severe COVID-19.
New discovery furthers our understanding of how critical immune cells are controlled during an infection
General Research
9 November 2023
A recent publication from Research from the Gerard Lab in Kennedy Institute of Rheumatology looks at how a specific protein, called IFNγ, can coordinate CD8+ T cell responses during a flu infection.
Partnership with Danaher paves way for precision medicine test for sepsis
General Research
8 November 2023
The University of Oxford today announced a partnership with Danaher Corporation to develop a new test to enable precision medicine care for sepsis, a pathological immune response to infection that accounts for one in five deaths globally each year.
Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa
General Innovation Research
6 November 2023
SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
General Research
6 November 2023
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, while also looking to improve manufacturing speed and scale-up of ChAdOx technology. Learnings could be leveraged to inform vaccine design for related viruses from the Arenavirus family, giving the world a head start in rapidly responding to future outbreaks in as little as 100 days. First project to be initiated under CEPI and University of Oxford’s strategic partnership to accelerate global pandemic preparedness efforts.
RECOVERY trial expands to investigate treatments for influenza
Coronavirus COVID-19 General Research
31 October 2023
The RECOVERY trial, which discovered four effective treatments for COVID-19, has expanded to investigate treatments for influenza (flu).
First digital atlas of human fetal brain development published
General Research
25 October 2023
The first digital atlas showing how the human brain develops in the womb has been published by a global research team led by the University of Oxford.
Estimating hospital-acquired SARS-CoV-2 infections in England
General Research
23 October 2023
An estimated 95,000–167,000 inpatients at English National Health Service (NHS) hospitals caught SARS-CoV-2 while in hospital during England’s ‘second wave’ of COVID-19, between June 2020 and March 2021, reports a study in Nature. The findings reveal the scale of hospital transmissions and highlight contributing factors, such as a limited number of single rooms.
New AI tool could help predict viral outbreaks
General Innovation Research
19 October 2023
As the COVID-19 pandemic demonstrated, viruses can quickly evolve new ways of evading our immune systems, undermining our efforts to control outbreaks. But a new artificial intelligence (AI) tool developed by researchers at the University of Oxford and Harvard Medical School could help predict new viral variants before they emerge. The findings have been published in the journal Nature.
Tackling mental illness by supporting industry to develop new drugs
General Innovation Research
11 October 2023
An academic/industry partnership, based at the NIHR Oxford Health Biomedical Research Centre, is helping companies use experimental medicine approaches to speed up development of new drugs to treat psychiatric disorders.
The Big Shot. Oxford, Africa and the R21 malaria vaccine
General Research
11 October 2023
What we desperately need are new tools to improve malaria control, and this is the first vaccine that can be deployed at scale, that will be affordable, and can be used widely in Africa on a scale of hundreds of millions of doses each year.
Oxford to lead global collaboration to research and develop next-generation COVID-19 and flu vaccines
Coronavirus COVID-19 General Research
11 October 2023
Project headed by Oxford University’s Professor Teresa Lambe OBE (Calleva Head of Vaccinology and Immunology, Department of Paediatrics) and co-developer of the Oxford/AstraZeneca COVID-19 vaccine and Paul Klenerman (Sidney Truelove Professor, Nuffield Department of Medicine)